Health Condition 1: - Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: Habb- e- Asgandh: dosage of intervention drug is 2 pills (each 650mg) at bed time for 45 days.
Control Intervention1: Tab. pregabalin: 75mg of tab. pregabalin is to be given once a day
Sponsors
Central Council of Research in Unani Medicine New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed patients of Diabetic Peripheral Neuropathy with type 2 Diabetes mellitus, having fasting blood sugar (FBS) from 140mg/dl up to 200mg/dl and post prandial (PPS) level from 200mg/dl up to 300mg/dl. - Patients between the ages of 30 to 60 years. 1. Patients irrespective of gender. 2. Patients having blood urea, serum creatinine, SGOT, SGPT within normal limit. 3. Patients willing to participate in the study and follow the instructions.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating mothers 2. Pathological status: cardiovascular disease, renal disease, hepatic disease. 3. Patients below 30 years and above 60 years of age. ï?? Complications of Diabetes other than Diabetic peripheral neuropathy. 4. Causes of Neuropathy other than Diabetes. 5. Patients who refuse to give the written consent for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetic Peripheral Neuropathy will be assessed by Toronto Clinical Neuropathy ScoreTimepoint: on 0 day, 15th day, 30th day and 45th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological tests include Hb%, TLC, DLC, ESR and Biochemical tests include Fasting blood sugar, Post prandial blood sugar, blood urea, serum creatinine, serum bilurubin, SGOT, SGPT, Total protein, Alkaline phosphataseTimepoint: before (0th day) and after intervention (45th day) | — |
Countries
India
Contacts
Public ContactDr Zaffar Hussain
Regional Research Institute of Unani Medicine, Srinagar
Outcome results
None listed